skip to main content
Back to all blog posts

Posted in: Intellectual Property

Mar 23, 2017

Canadian Federal Budget 2017 - Implications for Science and Innovation

By Kitt Sinden, M.Sc.

The latest Federal Budget was introduced in Canadian parliament on March 22, 2017, with a focus on, among other things, science and innovation. Budget 2017 proposes to elevate the importance of science in government, with the establishment of a Chief Science Advisor and related secretariat. The Chief Science Advisor will be responsible for providing advice to the Prime Minister and the Minister of Science, and to ensure that science is effectively communicated across government. In addition, over the coming year, the Government has pledged to work to develop a new federal science infrastructure strategy, including a review of existing investments in federal science infrastructure, such as federal laboratories and testing facilities, and the provision of a roadmap for future investments. Investments to support innovation and economic growth in stem cell research, space exploration, quantum information, social innovation and international research collaborations have been proposed.

Budget 2017 also recognizes the importance of a well-functioning intellectual property regime, announcing that the Government will develop a new intellectual property strategy over the coming year to help ensure that Canada's intellectual property regime is modern and robust and supports Canadian innovations in the 21st century.

A copy of Budget 2017 can be obtained by clicking here.

Related Categories

Related Blogs

Posted in: Intellectual Property | Court Decision

Insights TheSpotlight
Protection of Rights in Canada and International Comity Supreme Court of Canada Plants its Flag Down By Paige Backman, Aaron Baer and Codie Mitchell Jul 13, 2017 The Supreme Court of Canada’s recent and much-anticipated decision in Google Inc. v. Equustek Solutions Inc. is extremely important for many reasons. It has been applauded by Canadian companies whose intellectual property rights are being infringed by overseas companies, but, it has left ma...

Posted in: Intellectual Property

Insights TheSpotlight
Supreme Court of Canada Holds Promise of Utility Doctrine Incongruent with Patent Act AstraZeneca Canada Inc. et al. v. Apotex Inc. et al., 2017 SCC 36 By Kitt Sinden, M.Sc. Jun 30, 2017 Reasons for Judgement: Rowe J. (McLachlin, Abella, Moldaver, Karakatsanis, Wagner, Gascon, Côté and Brown concurring) On appeal from a judgment of the Federal Court of Appeal (2015 FCA 158) affirming a decision of Rennie J. (2014 FC 638) AstraZeneca applied for the 2,139,653 patent (...

Posted in: TheSpotlight Categories | Intellectual Property

Insights TheSpotlight
Canadian Court of Appeal has Something to Say on Obviousness: Critical of Rigid Tests and Using a Solution-Based Identification of the Inventive Concept that Excludes Serendipitous Discoveries Means Atazanavir Salt Obvious By Kitt Sinden, M.Sc. May 08, 2017 The Federal Court of Appeal (“FCA”) recently affirmed a Federal Court (“FC”) finding that an antiviral salt was obvious, although based on different reasoning1. The FCA provided a detailed analysis of the “inventive concept” (“IC”), although it is arguably still unclear as to when/why it is appro...